RMD - ResMed Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 522.3B
Enterprise Value 321.72B
Trailing P/E 49.22
Forward P/E 132.60
PEG Ratio (5 yr expected) 11.57
Price/Sales (ttm)8.01
Price/Book (mrq)9.88
Enterprise Value/Revenue 37.80
Enterprise Value/EBITDA 625.31

Trading Information

Stock Price History

Beta (5Y Monthly) 0.49
52-Week Change 335.62%
S&P500 52-Week Change 3-11.36%
52 Week High 3177.99
52 Week Low 396.81
50-Day Moving Average 3158.23
200-Day Moving Average 3149.93

Share Statistics

Avg Vol (3 month) 3739.36k
Avg Vol (10 day) 31.26M
Shares Outstanding 5143.79M
Float 143.23M
% Held by Insiders 10.80%
% Held by Institutions 170.71%
Shares Short (Mar. 12, 2020) 41.87M
Short Ratio (Mar. 12, 2020) 42.43
Short % of Float (Mar. 12, 2020) 41.46%
Short % of Shares Outstanding (Mar. 12, 2020) 41.29%
Shares Short (prior month Feb. 13, 2020) 42.37M

Dividends & Splits

Forward Annual Dividend Rate 41.56
Forward Annual Dividend Yield 41.10%
Trailing Annual Dividend Rate 31.54
Trailing Annual Dividend Yield 31.08%
5 Year Average Dividend Yield 41.61
Payout Ratio 448.56%
Dividend Date 3Mar. 18, 2020
Ex-Dividend Date 4Feb. 11, 2020
Last Split Factor 22:1
Last Split Date 3Aug. 30, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun. 29, 2019
Most Recent Quarter (mrq)Dec. 30, 2019


Profit Margin 16.34%
Operating Margin (ttm)25.03%

Management Effectiveness

Return on Assets (ttm)10.61%
Return on Equity (ttm)21.59%

Income Statement

Revenue (ttm)2.78B
Revenue Per Share (ttm)19.38
Quarterly Revenue Growth (yoy)13.10%
Gross Profit (ttm)1.54B
EBITDA 858.38M
Net Income Avi to Common (ttm)454.92M
Diluted EPS (ttm)3.13
Quarterly Earnings Growth (yoy)28.80%

Balance Sheet

Total Cash (mrq)204.1M
Total Cash Per Share (mrq)1.41
Total Debt (mrq)1.4B
Total Debt/Equity (mrq)61.95
Current Ratio (mrq)2.60
Book Value Per Share (mrq)15.62

Cash Flow Statement

Operating Cash Flow (ttm)513.76M
Levered Free Cash Flow (ttm)402.18M